Endpoint choice for inclusion body myositis: a step too far?
Author:
Publisher
Elsevier BV
Subject
Clinical Neurology
Reference9 articles.
1. Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment;Schmidt;Curr Opin Rheumatol,2017
2. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial;Hanna;Lancet Neurol,2019
3. An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy;Lach-Trifilieff;Mol Cell Biol,2014
4. Treatment of sporadic inclusion body myositis with bimagrumab;Amato;Neurology,2014
5. Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study;Rooks;J Am Geriatr Soc,2017
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Quantitative muscle MRI in sporadic inclusion body myositis (sIBM): A prospective cohort study;Journal of Neuromuscular Diseases;2024-09-03
2. Inclusion body myositis—health-related quality of life and care situation during phases of the “patience journey” in Germany: results from a qualitative study;Health and Quality of Life Outcomes;2023-10-10
3. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial;The Lancet Neurology;2023-10
4. The health-related quality of life, mental health and mental illnesses of patients with inclusion body myositis (IBM): results of a mixed methods systematic review;Orphanet Journal of Rare Diseases;2022-06-16
5. In Pursuit of an Effective Treatment: the Past, Present and Future of Clinical Trials in Inclusion Body Myositis;Current Treatment Options in Rheumatology;2021-02-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3